{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T17:20:20Z","timestamp":1777310420347,"version":"3.51.4"},"reference-count":18,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T00:00:00Z","timestamp":1591056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Background: Mycetoma and chromoblastomycosis are both chronic subcutaneous infectious diseases that pose an obstacle to socioeconomic development. Besides the therapeutic issue, the diagnosis of most neglected tropical diseases (NTD) is challenging. Confirmation using direct microscopy and culture, recognized as WHO essential diagnostic tests, are limited to specialized facilities. In this context, there is a need for simple user-friendly diagnostic tests to be used in endemic villages. Methods: This review discuss the available biomarkers that could help to improve the diagnostic capacity for mycetoma and chromoblastomycosis in a theoretical and practical perspective. Results: A lack of research in this area has to be deplored, mainly for mycetoma. Biomarkers based on the immune response (pattern of leucocytes, antibody detection), the dermal involvement (extracellular matrix monitoring, protein expression), and the presence of the infectious agent (protein detection) are potential candidates for the detection or follow-up of infection. Conclusion: Confirmatory diagnosis based on specific diagnostic biomarkers will be the basis for the optimal treatment of mycetoma and chromoblastomycosis. It will be part of the global management of NTDs under the umbrella of stewardship activities.<\/jats:p>","DOI":"10.3390\/molecules25112594","type":"journal-article","created":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T04:12:09Z","timestamp":1591157529000},"page":"2594","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Mycetoma and Chromoblastomycosis: Perspective for Diagnosis Improvement Using Biomarkers"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1502-1851","authenticated-orcid":false,"given":"Anne-Lise","family":"Bienvenu","sequence":"first","affiliation":[{"name":"Service Pharmacie, Groupement Hospitalier Nord, Hospices Civils de Lyon, 69004 Lyon, France"},{"name":"Service d\u2019H\u00e9matologie, Groupement Hospitalier Nord, Hospices Civils de Lyon, 69004 Lyon, France"},{"name":"Malaria Research Unit, University Lyon, ICBMS, UMR 5246 CNRS INSA CPE, Campus Lyon-Tech La Doua, F-69100 Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5735-6759","authenticated-orcid":false,"given":"Stephane","family":"Picot","sequence":"additional","affiliation":[{"name":"Malaria Research Unit, University Lyon, ICBMS, UMR 5246 CNRS INSA CPE, Campus Lyon-Tech La Doua, F-69100 Lyon, France"},{"name":"Groupement Hospitalier Nord, Institut de Parasitologie et Mycologie M\u00e9dicale, Hospices Civils de Lyon, 69004 Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,6,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"van de Sande, W.W.J. (2013). Global burden of human mycetoma: A systematic review and meta-analysis. PLoS Negl. Trop. Dis., 7.","DOI":"10.1371\/journal.pntd.0002550"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e367","DOI":"10.1016\/S1473-3099(17)30306-7","article-title":"Neglected endemic mycoses","volume":"17","author":"Fahal","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Fahal, A.H. (2017). Mycetoma: A global medical and socio-economic dilemma. PLoS Negl. Trop. Dis., 11.","DOI":"10.1371\/journal.pntd.0005509"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Hay, R., Denning, D.W., Bonifaz, A., Queiroz-Telles, F., Beer, K., Bustamante, B., Chakrabarti, A., Chavez-Lopez, M.d.G., Chiller, T., and Cornet, M. (2019). The Diagnosis of Fungal Neglected Tropical Diseases (Fungal NTDs) and the Role of Investigation and Laboratory Tests: An Expert Consensus Report. Trop. Med. Infect. Dis., 4.","DOI":"10.3390\/tropicalmed4040122"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s11046-019-00359-2","article-title":"New Molecular Markers Distinguishing Fonsecaea Agents of Chromoblastomycosis","volume":"184","author":"Schneider","year":"2019","journal-title":"Mycopathologia"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1128\/JCM.00417-17","article-title":"Rapid and Robust Identification of the Agents of Black-Grain Mycetoma by Matrix-Assisted Laser Desorption Ionization\u2013Time of Flight Mass Spectrometry","volume":"55","author":"Fraser","year":"2017","journal-title":"J. Clin. Microbiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"332","DOI":"10.4103\/ijd.IJD_476_16","article-title":"Mycetoma: An update","volume":"62","author":"Relhan","year":"2017","journal-title":"Indian J. Dermatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0001-706X(03)00139-6","article-title":"Lymphocyte subsets, macrophages and Langerhans cells in actinomycetoma and eumycetoma tissue reaction","volume":"87","author":"Castro","year":"2003","journal-title":"Acta Trop."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"310","DOI":"10.5114\/pdia.2014.40949","article-title":"Chromoblastomycosis","volume":"5","year":"2014","journal-title":"Postepy Dermatol. Alergol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1590\/S0036-46652007000100009","article-title":"The pattern of immune cell infiltration in chromoblastomycosis: Involvement of macrophage inflammatory protein-1 alpha\/CCL3 and fungi persistence","volume":"49","author":"Silva","year":"2007","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1189\/jlb.0308211","article-title":"Fonsecaea pedrosoi infection induces differential modulation of costimulatory molecules and cytokines in monocytes from patients with severe and mild forms of chromoblastomycosis","volume":"84","author":"Sousa","year":"2008","journal-title":"J. Leukoc. Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.micinf.2005.01.006","article-title":"Cytokines and lymphocyte proliferation in patients with different clinical forms of chromoblastomycosis","volume":"7","author":"Ferreira","year":"2005","journal-title":"Microbes Infect."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1007\/s10096-014-2138-3","article-title":"Association of IgG immunoglobulin and subclasses level with the severity of chromoblastomycosis due to Fonsecaea pedrosoi and therapeutic response to itraconazole","volume":"33","author":"Marques","year":"2014","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_14","first-page":"479","article-title":"Anti-neutrophil cytoplasmic antibodies in patients with chromomycosis","volume":"14","author":"Galperin","year":"1996","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0733-8635(05)70327-2","article-title":"Chromoblastomycosis","volume":"14","author":"Elgart","year":"1996","journal-title":"Dermatol. Clin."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1046\/j.1365-2362.1998.00335.x","article-title":"Monitoring of extracellular matrix metabolism and cross-linking in tissue, serum and urine of patients with chromoblastomycosis, a chronic skin fibrosis","volume":"28","author":"Hartmann","year":"1998","journal-title":"Eur. J. Clin. Invest."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.4049\/jimmunol.177.3.1997","article-title":"Translationally controlled tumor protein from Madurella mycetomatis, a marker for tumorous mycetoma progression","volume":"177","author":"Janse","year":"2006","journal-title":"J. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/DAD.0000000000000781","article-title":"Galectin-3 Expression in Benign and Malignant Skin Diseases With Epidermal Hyperplasia","volume":"39","author":"Jiang","year":"2017","journal-title":"Am. J. Dermatopathol."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/25\/11\/2594\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:35:09Z","timestamp":1760175309000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/25\/11\/2594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,2]]},"references-count":18,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,6]]}},"alternative-id":["molecules25112594"],"URL":"https:\/\/doi.org\/10.3390\/molecules25112594","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,2]]}}}